Advances in the management of childhood leukemia.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology; D016026:Bone Marrow Transplantation; D002648:Child; D006801:Humans; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D007948:Leukemia, Monocytic, Acute / Q000628:therapy; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008215:Lymphocytes, Null / Q000276:immunology; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009423:Nervous System Neoplasms / Q000517:prevention & control / Q000556:secondary; D010641:Phenotype; D011379:Prognosis; D011878:Radiotherapy; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors
D000970:Antineoplastic Agents